RECORDATI: Rob Koremans new Chief Executive Officer effective 1 December 2021, Andrea Recordati to be appointed as Chairman.

https://www.marketscreener.com/quote/stock/RECORDATI-159075/news/RECORDATI-Rob-Koremans-new-Chief-Executive-Officer-effective-1-December-2021-Andrea-Recordati-to-b-35874503/

Participants

  • Rob Koremans
    Role: Alumni
    Reference type: Referenced

Media outlets

  • MarketScreener (Online)

Description

Rob Koremans new Chief Executive Officer effective 1 December 2021, Andrea Recordati to be appointed as Chairman. Rob Koremans qualified as a medical doctor from RSM Erasmus University in the Netherlands and has over 30 years' experience in managerial and executive roles, gained mainly in the pharmaceutical industry at various international companies, including Serono, Grünenthal, Sanofi-Aventis and Teva.

Rob Koremans new Chief Executive Officer effective 1 December 2021, Andrea Recordati to be appointed as Chairman. Rob Koremans qualified as a medical doctor from RSM Erasmus University in the Netherlands and has over 30 years' experience in managerial and executive roles, gained mainly in the pharmaceutical industry at various international companies, including Serono, Grünenthal, Sanofi-Aventis and Teva.